To assess the prevalence of proximal FA pathway inactivation in HCC, 18 surgical HCC tissue specimens were analyzed for inactivation of FANCC, FANCF or FANCG through screening for genetic mutations, epigenetic silencing through CpG hypermethylation or lack of mRNA-expression. This evidence concerns the gene FANCF and hepatocellular carcinoma.